IRADIMED Management
Management criteria checks 4/4
IRADIMED's CEO is Roger Susi, appointed in Jan 2004, has a tenure of 20.25 years. total yearly compensation is $586.04K, comprised of 49.5% salary and 50.5% bonuses, including company stock and options. directly owns 36.23% of the company’s shares, worth $190.26M. The average tenure of the management team and the board of directors is 2.8 years and 7.8 years respectively.
Key information
Roger Susi
Chief executive officer
US$586.0k
Total compensation
| CEO salary percentage | 49.5% |
| CEO tenure | 20.3yrs |
| CEO ownership | 36.2% |
| Management average tenure | 2.8yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity
Feb 23
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely
Feb 07Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?
Nov 06Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)
Oct 13At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?
Feb 05Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y
Oct 10IRadimed: Record Revenue Could Translate To Share Price Appreciation
Aug 23Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching
Aug 17iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M
Jul 29IRadimed: Reduce Equity Beta With Upside Capture
Jul 18IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively
Jul 13At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?
Feb 05Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital
Jan 12Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture
Jul 13iRadimed EPS beats by $0.04, beats on revenue
Apr 30iRadimed EPS misses by $0.02, beats on revenue
Feb 04If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today
Jan 31
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$17m |
| Sep 30 2023 | n/a | n/a | US$16m |
| Jun 30 2023 | n/a | n/a | US$15m |
| Mar 31 2023 | n/a | n/a | US$14m |
| Dec 31 2022 | US$586k | US$290k | US$13m |
| Sep 30 2022 | n/a | n/a | US$13m |
| Jun 30 2022 | n/a | n/a | US$12m |
| Mar 31 2022 | n/a | n/a | US$10m |
| Dec 31 2021 | US$615k | US$308k | US$9m |
| Sep 30 2021 | n/a | n/a | US$6m |
| Jun 30 2021 | n/a | n/a | US$5m |
| Mar 31 2021 | n/a | n/a | US$987k |
| Dec 31 2020 | US$435k | US$290k | US$1m |
| Sep 30 2020 | n/a | n/a | US$4m |
| Jun 30 2020 | n/a | n/a | US$5m |
| Mar 31 2020 | n/a | n/a | US$10m |
| Dec 31 2019 | US$488k | US$288k | US$10m |
| Sep 30 2019 | n/a | n/a | US$8m |
| Jun 30 2019 | n/a | n/a | US$8m |
| Mar 31 2019 | n/a | n/a | US$7m |
| Dec 31 2018 | US$495k | US$279k | US$6m |
| Sep 30 2018 | n/a | n/a | US$5m |
| Jun 30 2018 | n/a | n/a | US$3m |
| Mar 31 2018 | n/a | n/a | US$2m |
| Dec 31 2017 | US$474k | US$268k | US$500k |
Compensation vs Market: Roger's total compensation ($USD586.04K) is below average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Roger's compensation has been consistent with company performance over the past year.
CEO
Roger Susi (70 yo)
20.3yrs
Tenure
US$586,040
Compensation
Mr. Roger E. Susi serves as President and Chief Executive Officer of IRadimed Corporation since May 28, 2020. He founded IRadimed Corporation in 2004 and has been its Chairman of the Board since June 10, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 20.3yrs | US$586.04k | 36.23% $ 190.3m | |
| CFO & Corporate Secretary | 1.8yrs | US$1.86m | 0.054% $ 285.4k | |
| Vice President of Worldwide Sales & Marketing | 2.8yrs | US$560.02k | 0.047% $ 248.6k | |
| Vice President of Regulatory Affairs & Quality Assurance | no data | US$425.08k | 0.014% $ 75.0k | |
| Vice President of Research & Development | no data | US$442.20k | 0.017% $ 89.2k | |
| Executive Vice President of Continuous Improvement & Information Technology | 1.8yrs | no data | no data | |
| Controller | 4.3yrs | no data | no data |
2.8yrs
Average Tenure
Experienced Management: IRMD's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 7.8yrs | US$586.04k | 36.23% $ 190.3m | |
| Director | 4.8yrs | US$158.74k | 0.31% $ 1.6m | |
| Independent Director | 8.1yrs | US$163.74k | 0.13% $ 701.9k | |
| Independent Director | 10.3yrs | US$166.24k | 0.16% $ 829.4k | |
| Independent Director | 1.5yrs | US$165.62k | 0.014% $ 73.2k |
7.8yrs
Average Tenure
70yo
Average Age
Experienced Board: IRMD's board of directors are considered experienced (7.8 years average tenure).